Clinical trial · Interventional
Reproductive Health Program in Patients With Cancer
EROS: Engendering Reproductive Health Within Oncologic Survivorship
NCT01806129CI-TRIAL-00113488EROSactive not recruitingN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard practice related to reproductive heath | Other | — | UNRESOLVED |
| Training modules, algorithm, referral development | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Arm A (no intervention)
- description
- Patients undergo usual standard practice related to reproductive health.
- interventionNames
- Other: Standard practice related to reproductive heath
- type
- EXPERIMENTAL
- label
- Arm B (reproductive health program)
- description
- Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.
- interventionNames
- Other: Training modules, algorithm, referral development
Primary outcomes (1)
- measure
- Proportion of Patients With Appropriate Reproductive Health Management
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 15 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients presenting with initial diagnosis of any type of cancer, including patients with ductal carcinoma in situ (DCIS) * Pre-menopausal patients within the reproductive age range of 15-55 years; pre-menopausal is defined as females meeting the following criteria: * Patients not currently on hormonal contraception with the presence of menses in the past 6 months * If no menstruation in the past 6 months, without hormonal manipulation, then confirmed follicle-stimulating hormone (FSH) \< 23mlU/mL * If age \< 47 years and on hormonal contraception, then patient will be eligible regardless of menstrual history * If age ≥ 47 years and on hormonal contraception, then FSH confirmed \< 23mIU/mL * Pregnant women are eligible to participate in this study * Patients must have the cognitive ability to participate in the study Exclusion Criteria: * Patients who have initiated chemotherapy, radiation therapy or endocrine therapy prior to registration to this study * Prior hysterectomy, bilateral oophorectomy or sterilization of any method
References
Publications (0)
Data not yet available
No reference posted for this study.